In a breast cancer model, pharmacologic inhibition of ILK with QLT0267 was shown to be synergistic with docetaxel, demonstrating enhanced cytotoxic activity, significantly reduced tumor growth, and enhanced survival compared to either agent alone [55]. This evidence concerns the gene ILK and neoplasm.